Endocrine Peptide Test Market - Global Industry Analysis

Endocrine Peptide Test Market By Test Type (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Estradiol, Gonadotropin, Thyroid-stimulating Hormone, and Others), By End-User (Clinics, Healthcare Centers, Hospitals, and Commercial Laboratories), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 04-Jul-2022 Category: Healthcare Report Format : PDF Pages: 260 Report Code: ZMR-7007 Status : Published

The global endocrine peptide test market was worth around $7.04 billion in 2021 and is predicted to grow to around $11 billion by 2028 at a CAGR rate of 8% over the forecast period.

Description

Industry Prospective

The global endocrine peptide test market was worth around $7.04 billion in 2021 and is predicted to grow to around $11 billion by 2028 at a CAGR rate of 8% over the forecast period. In this report, we will cover the full overview, growth drivers, opportunities, and obstacles of the endocrine peptide test market from 2022 -to 2028

Endocrine Peptide Test Market: Overview

Endocrine peptide test is done to measure the level of C-peptide present in the bloodstream. They are very similar to insulin and they both are found in equal quantities in the body. The quantity of glucose is managed by insulin. The C-peptide measures the insulin secreted by the pancreas.

The sugar level in a person has no bearing on the c-peptide. It just gives the measure to indicate the insulin levels to test whether they are normal or below nominal. C-peptide is otherwise termed a connecting peptide. It is basically 31-amino acid polypeptide. This test is done to check whether somebody is diabetic-prone or the type of diabetes they have.

The test is basically performed by injecting the glucose inside the body and radiating energy. This will show the result as to what amount of C-peptide is actually present. They are also used to diagnose similar diseases with the measurement of C-peptide levels in the blood serum.

Global Endocrine Peptide Test Market

Covid-19 Impact:

The exponential increase in the number of infected patients during the pandemic triggered a huge demand for specialist treatment methods and tests. The healthcare infrastructure that is currently available was not capable enough to treat millions of people who fell ill during the pandemic times. Any chance to improve diagnosis methods and treatments was implemented and supported by the governments to satisfy the massive demand. Hence the endocrine peptide test market grew at a considerable rate with so many diabetic and immuno-compromised people waiting to get tested when the pandemic was in a rage. Although people suffered to commute to reach clinics and hospitals due to severe lockdowns and curfews, the demand for such testing routines increased rapidly.

 Endocrine Peptide Test Market: Growth Drivers

Prevalence of diabetes amongst the masses induces market growth

One of the main factors that propel the demand for endocrine peptide testing is the extreme prevalence of diabetic patients all over the world. Thyroid disorders and infertility have also been very predominant in recent times which triggers excessive leverage of endocrine peptide tests.

The other factors which drive market growth t a large extent are supposed to be the decreasing level of immunity in people across the world. There is always a high risk of contracting any chronic diseases because of the complications that prevail today amongst people. Technological advancements in medical fields with testing and diagnosing methods have become more prominent and any infrastructural improvisations along those lines are welcomed & accepted exclusively. This also boosts growth in the global endocrine peptide test market as many people consume the test in excess.

Home-based diagnoses for all sicknesses and diseases are also gaining a lot of demand. The easily accessible kits make the testing easier for people as the geriatric population in every region has increased to a certain level. The complications and risk of developing chronic diseases amongst the older population have triggered them to opt for self-diagnosis and treatment methods. These cost-effective diagnostic kits for home testing also improve the leverage quotient of the tests thereby spiking up the market rate.

Endocrine Peptide Test Market: Restraints

High costs associated with endocrine peptide testing methods hamper the market growth

The cost and expenses associated with these testing methods impede market growth to a certain extent. Lack of awareness and appropriate healthcare infrastructures to provide these tests in developing countries also lessen the consumption of these diagnostic tests. All these factors restrain the market growth of endocrine peptide tests to a large extent

Endocrine Peptide Tests Market: Opportunities

Advancement in the endocrine testing method to bring precision is a great opportunity for market expansion

The endocrine peptide tests conducted in recent times are now integrated with mass spectrometry to increase the accuracy of the result. This aids the testing methods to be fully automated and brings precision to the output thereby improving the consumption rate. This factor provides lucrative opportunities for market expansion in the future.

Endocrine Peptide Tests Market: Challenges

High costs associated with these testing methods pose a challenge to the market

The affordability and accessibility of these endocrine testing in developing countries are still a problem due to the high cost associated with these testing methods. The rising prominence of diseases and chronic illness across the world trigger people to opt for low-cost testing methods. This factor poses a challenge to the market growth of the global endocrine peptide test market.

Lack of proper healthcare infrastructure also poses a challenge to the market growth

Many developing countries across the world suffer from the evident lack of good healthcare infrastructures to support such testing methods. Hence the accessibility of these endocrine peptide testing methods is very low which induces a challenge to the global market.

Endocrine Peptide Test Market: Segmentation

The global endocrine peptide test market is fragmented into its test type, end-user industry, and region. On the basis of the test type, the global market is segregated into dehydroepiandrosterone sulfate, progesterone, luteinizing hormone, thyroid prolactin, oestradiol, human chorionic gonadotropin, thyroid-stimulating hormone, and others. On the basis of the end-user industry, the market is categorized into clinics, healthcare centers, hospitals, and commercial laboratories.

Recent Developments:

In June 2022, at ENDO 2022, the Endocrine Society presented a clinical study about the development of PEC-Direct, a stem cell-based therapy to treat high-risk type 1 diabetes. It is deemed to function as a replacement pancreas.

Regional Landscape:

North America leads as the major contributor to the global endocrine peptide tests market due to the excessive presence of endocrine disorders in that region. There is also an increase in the overall rate of the geriatric population which leads to an increase in the leverage of endocrine tests. Western Europe trails as the second-best contributor to the global market owing to the improving healthcare infrastructures. Government initiatives to ease the affordability and accessibility of healthcare services trigger a huge demand thereby improving the market rate as well.

Competitive Landscape:

The key global endocrine peptide test market players are Agilent Technologies, Abbott Laboratories, Biomedical Diagnostics, Bio-Rad Laboratories, Hoffman- La Roche Ltd, ImmunoDX, Laboratory Corporation, Nano Entek, Siemens AG, Thermo Fischer Scientific Inc., and BioMerieux.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Endocrine Peptide Test Market is segmented as below:

By Test-Type

  • Dehydroepiandrosterone Sulphate
  • Progesterone
  • Luteinizing hormone
  • Thyroid Prolactin
  • Oestradiol
  • Human Chorionic Gonadotropin
  • Thyroid-stimulating Hormone
  • Others

By End-Users

  • Clinics
  • Healthcare Centers
  • Hospitals
  • Commercial Laboratories

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Endocrine Peptide Test Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Endocrine Peptide Test Market : snapshot
  • Chapter 3. Global Endocrine Peptide Test Market - Industry Analysis
    • 3.1 Endocrine Peptide Test Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Prevalence of diabetes amongst the masses induces market growth
    • 3.3 Market Restraints
      • 3.3.1. High costs associated with endocrine peptide testing methods hamper the market growth
    • 3.4 Market Opportunities
      • 3.4.1. Advancement in the endocrine testing method to bring precision is a great opportunity for market expansion
    • 3.5 Market Challenges
      • 3.5.1. High costs associated with these testing methods pose a challenge to the market
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Test-Type
      • 3.7.2 Market attractiveness analysis By End-Users
  • Chapter 4. Global Endocrine Peptide Test Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Endocrine Peptide Test Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Endocrine Peptide Test Market - Test-Type Analysis
    • 5.1 Global Endocrine Peptide Test Market overview: By Test-Type
      • 5.1.1 Global Endocrine Peptide Test Market share, By Test-Type, 2021 and 2028
    • 5.2 Dehydroepiandrosterone Sulphate
      • 5.2.1 Global Endocrine Peptide Test Market by Dehydroepiandrosterone Sulphate, 2022 - 2028 (USD Billion)
    • 5.3 Progesterone
      • 5.3.1 Global Endocrine Peptide Test Market by Progesterone, 2022 - 2028 (USD Billion)
    • 5.4 Luteinizing hormone
      • 5.4.1 Global Endocrine Peptide Test Market by Luteinizing hormone, 2022 - 2028 (USD Billion)
    • 5.5 Thyroid Prolactin
      • 5.5.1 Global Endocrine Peptide Test Market by Thyroid Prolactin, 2022 - 2028 (USD Billion)
    • 5.6 Oestradiol
      • 5.6.1 Global Endocrine Peptide Test Market by Oestradiol, 2022 - 2028 (USD Billion)
    • 5.7 Human Chorionic Gonadotropin
      • 5.7.1 Global Endocrine Peptide Test Market by Human Chorionic Gonadotropin, 2022 - 2028 (USD Billion)
    • 5.8 Thyroid-stimulating Hormone
      • 5.8.1 Global Endocrine Peptide Test Market by Thyroid-stimulating Hormone, 2022 - 2028 (USD Billion)
    • 5.9 Others
      • 5.9.1 Global Endocrine Peptide Test Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 6. Global Endocrine Peptide Test Market - End-Users Analysis
    • 6.1 Global Endocrine Peptide Test Market overview: By End-Users
      • 6.1.1 Global Endocrine Peptide Test Market share, By End-Users, 2021 and 2028
    • 6.2 Clinics
      • 6.2.1 Global Endocrine Peptide Test Market by Clinics, 2022 - 2028 (USD Billion)
    • 6.3 Healthcare Centers
      • 6.3.1 Global Endocrine Peptide Test Market by Healthcare Centers, 2022 - 2028 (USD Billion)
    • 6.4 Hospitals
      • 6.4.1 Global Endocrine Peptide Test Market by Hospitals, 2022 - 2028 (USD Billion)
    • 6.5 Commercial Laboratories
      • 6.5.1 Global Endocrine Peptide Test Market by Commercial Laboratories, 2022 - 2028 (USD Billion)
  • Chapter 7. Endocrine Peptide Test Market - Regional Analysis
    • 7.1 Global Endocrine Peptide Test Market Regional Overview
    • 7.2 Global Endocrine Peptide Test Market Share, by Region, 2021 & 2028 (USD Billion)
    • 7.3. North America
      • 7.3.1 North America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
        • 7.3.1.1 North America Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 North America Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
      • 7.4.1 North America Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
    • 7.5 North America Endocrine Peptide Test Market, by End-Users, 2022 - 2028
      • 7.5.1 North America Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
    • 7.4. Europe
      • 7.4.2 Europe Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
        • 7.4.2.1 Europe Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 Europe Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
      • 7.4.1 Europe Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
    • 7.5 Europe Endocrine Peptide Test Market, by End-Users, 2022 - 2028
      • 7.5.1 Europe Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
        • 7.5.3.1 Asia Pacific Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 Asia Pacific Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
      • 7.4.1 Asia Pacific Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
    • 7.5 Asia Pacific Endocrine Peptide Test Market, by End-Users, 2022 - 2028
      • 7.5.1 Asia Pacific Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
    • 7.6. Latin America
      • 7.6.4 Latin America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
        • 7.6.4.1 Latin America Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 Latin America Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
      • 7.4.1 Latin America Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
    • 7.5 Latin America Endocrine Peptide Test Market, by End-Users, 2022 - 2028
      • 7.5.1 Latin America Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
        • 7.7.5.1 The Middle-East and Africa Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 The Middle-East and Africa Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
      • 7.4.1 The Middle-East and Africa Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
    • 7.5 The Middle-East and Africa Endocrine Peptide Test Market, by End-Users, 2022 - 2028
      • 7.5.1 The Middle-East and Africa Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1 Agilent Technologies
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Abbott Laboratories
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Biomedical Diagnostics
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Bio-Rad Laboratories
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Hoffman- La Roche Ltd
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 ImmunoDX
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Laboratory Corporation
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Nano Entek
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Siemens AG
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Thermo Fischer Scientific Inc.
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments
    • 8.11 BioMerieux.
      • 8.11.1 Overview
      • 8.11.2 Financials
      • 8.11.3 Product Portfolio
      • 8.11.4 Business Strategy
      • 8.11.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Endocrine Peptide Test Market attractiveness, By Test-Type
  • 6. Global Endocrine Peptide Test Market attractiveness, By End-Users
  • 7. Global Endocrine Peptide Test Market share by Test-Type, 2022 and 2028 (USD Billion)
  • 8. Global Endocrine Peptide Test Market by Dehydroepiandrosterone Sulphate, 2022 - 2028 (USD Billion)
  • 9. Global Endocrine Peptide Test Market by Progesterone, 2022 - 2028 (USD Billion)
  • 10. Global Endocrine Peptide Test Market by Luteinizing hormone, 2022 - 2028 (USD Billion)
  • 11. Global Endocrine Peptide Test Market by Thyroid Prolactin, 2022 - 2028 (USD Billion)
  • 12. Global Endocrine Peptide Test Market by Oestradiol, 2022 - 2028 (USD Billion)
  • 13. Global Endocrine Peptide Test Market by Human Chorionic Gonadotropin, 2022 - 2028 (USD Billion)
  • 14. Global Endocrine Peptide Test Market by Thyroid-stimulating Hormone, 2022 - 2028 (USD Billion)
  • 15. Global Endocrine Peptide Test Market by Others, 2022 - 2028 (USD Billion)
  • 16. Global Endocrine Peptide Test Market share by End-Users, 2022 and 2028 (USD Billion)
  • 17. Global Endocrine Peptide Test Market by Clinics, 2022 - 2028 (USD Billion)
  • 18. Global Endocrine Peptide Test Market by Healthcare Centers, 2022 - 2028 (USD Billion)
  • 19. Global Endocrine Peptide Test Market by Hospitals, 2022 - 2028 (USD Billion)
  • 20. Global Endocrine Peptide Test Market by Commercial Laboratories, 2022 - 2028 (USD Billion)
  • 21. Global Endocrine Peptide Test Market share, by Region, 2022 and 2028
  • 22. North America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
  • 23. Europe Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
  • 24. Asia Pacific Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
  • 25. Latin America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
  • 26. The Middle-East and Africa Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Endocrine Peptide Test Market: Snapshot
  • 2. Drivers of the Endocrine Peptide Test Market: impact analysis
  • 3. North America Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 4. North America Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 5. U.S. Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 6. U.S. Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 7. Canada Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 8. Canada Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 9. Europe Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 10. Europe Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 11. Germany Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 12. Germany Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 13. France Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 14. France Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 15. U.K. Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 16. U.K. Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 17. Italy Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 18. Italy Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 19. Spain Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 20. Spain Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 21. Rest of Europe Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 22. Rest of Europe Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 23. Asia Pacific Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 24. Asia Pacific Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 25. China Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 26. China Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 27. Japan Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 28. Japan Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 29. India Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 30. India Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 31. South Korea Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 32. South Korea Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 33. South-East Asia Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 34. South-East Asia Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 35. Rest of Asia Pacific Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 36. Rest of Asia Pacific Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 37. Latin America Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 38. Latin America Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 39. Brazil Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 40. Brazil Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 41. Mexico Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 42. Mexico Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 43. Rest of Latin America Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 44. Rest of Latin America Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 45. The Middle-East and Africa Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 46. The Middle-East and Africa Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 47. GCC Countries Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 48. GCC Countries Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 49. South Africa Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 50. South Africa Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
  • 51. Rest of Middle-East Africa Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
  • 52. Rest of Middle-East Africa Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

One of the main factors that propel the demand for endocrine peptide testing is the extreme prevalence of diabetic patients all over the world. Thyroid disorders and infertility have also been very predominant in recent times which triggers excessive leverage of endocrine peptide tests.

The global Endocrine Peptide Test market was worth around $7.04 billion in 2021 and is predicted to grow to around $11 billion by 2028 at a CAGR rate of 8% over the forecast period. In this report, we will cover the full overview, growth drivers, opportunities, and obstacles of the bubble tea market from 2022 -to 2028

North America leads as the major contributor to the endocrine peptide tests market due to the excessive presence of endocrine disorders in that region. There is also an increase in the overall rate of the geriatric population which leads to an increase in the leverage of endocrine tests.

The key market players are Agilent Technologies, Abbott Laboratories, Biomedical Diagnostics, Bio-Rad Laboratories, Hoffman- La Roche Ltd, ImmunoDX, Laboratory Corporation, Nano Entek, Siemens AG, Thermo Fischer Scientific Inc., and BioMerieux.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed